Alnylam Pharmaceuticals (ALNY -0.9%) will discuss full results from the ILLUMINATE-A Phase 3 study of lumasiran in a webcast conference call on Sunday, June 7, at 8:30 am ET.
The clinical data will be presented at the
European Renal Association-European Dialysis and Transplant Association
International Congress being held June 6-9 as a virtual event.
https://seekingalpha.com/news/3579031-alnylam-to-host-webcast-on-illuminate-study-of-lumasiran-on-june-7
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.